title: Bendamustine-rituximab in mantle cell lymphoma.
authors.affiliation: Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Lipsky
authors.affiliation: Weill Cornell Medicine, Cornell University, New York, NY 10065, USA. Electronic address: pem9019@med.cornell.edu.
authors.forename: Peter
authors.initials: P
authors.lastname: Martin
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D000074322:Antineoplastic Agents, Immunological; D003561:Cytarabine; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride